瑞士HIV队列研究中男男性行为者丙型肝炎消除的持续效果:全国性消除项目后两年对丙型肝炎RNA的系统性再筛查
基于瑞士HIV队列研究,对男男性行为者(MSM)在2019年用储存血浆筛查HCV RNA,即「Swiss HCVree Post」筛查(N=4641),点患病率为0.6%,较Swiss HCVree试验结束时的1.2%下降48%;HCV发病率从2017年的0.31/100人年(95%CI 0.17-0.55)降至2019年的0.19/100人年(95%CI 0.09-0.39)。
要点
- Swiss HCVree Post筛查(N=4641)HCV RNA点患病率为0.6%,较试验结束时1.2%下降48%。
- MSM中HCV发病率从2017年0.31/100人年降至2019年0.19/100人年(95%CI 0.09-0.39)。
- 系统筛查显示Swiss HCVree试验对瑞士HIV合并MSM人群HCV疫情有持续遏制效果。
核心结论
- Swiss HCVree试验后2年对HIV合并MSM进行系统性HCV RNA筛查,显示复制的HCV感染患病率和发病率持续下降,表明该试验成功遏制了瑞士HIV合并MSM人群的HCV疫情。
研究设计与样本
- 对瑞士HIV队列研究中所有MSM,使用2019年储存血浆样本筛查HCV RNA,称为「Swiss HCVree Post」筛查;利用队列常规收集的HCV检测信息评估HCV感染发病率随时间的变化。
主要发现
- 「Swiss HCVree Post」筛查(N=4641)HCV RNA点患病率为0.6%,较Swiss HCVree试验结束时1.2%下降48%。
- 瑞士HIV队列研究中MSM的HCV发病率从2017年0.31/100人年(95%CI 0.17-0.55)降至2019年0.19/100人年(95%CI 0.09-0.39)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Swiss HCVree Trial (NCT02785666) was conducted in 2015-2017 with the goal of implementing a population-based systematic hepatitis C virus (HCV) micro-elimination program among men who have sex with men (MSM) with human immunodeficiency virus (HIV) enrolled in the Swiss HIV Cohort Study (SHCS). The trial led to a 91% and 77% decline of HCV prevalence and incidence, respectively. The long-term effect of this HCV micro-elimination program is yet to be explored. METHODS: All MSM enrolled in the SHCS were screened for HCV RNA using stored plasma samples obtained in 2019, termed "Swiss HCVree Post" screen. The incidence of HCV infection over time was assessed using additional information on HCV testing routinely collected in the SHCS. Characteristics of participants with replicating HCV infection were analyzed. RESULTS: The point-prevalence of "Swiss HCVree Post" (N = 4641) was 0.6%, reflecting a decline of 48% compared to the end of the Swiss HCVree Trial where the prevalence was 1.2%. Further, the incidence of HCV among MSM in the SHCS declined from 0.31/100 person-years (py) (95% confidence interval [CI] [.17, .55]) in 2017 to 0.19/100 py (95% CI [.09, .39]) in 2019. CONCLUSIONS: A systematic HCV RNA-based screening among MSM with HIV conducted 2 years after the Swiss HCVree Trial revealed a sustained effect and further decline of the prevalence and incidence of replicating HCV infection. This indicates that the Swiss HCVree Trial was successful in curbing the HCV epidemic among MSM with HIV in Switzerland. CLINICAL TRIALS REGISTRATION: NCT02785666.
引用
- Kusejko K, Salazar-Vizcaya L, Shah C, et al. Sustained Effect on Hepatitis C Elimination Among Men Who Have Sex With Men in the Swiss HIV Cohort Study: A Systematic Re-Screening for Hepatitis C RNA Two Years Following a Nation-Wide Elimination Program. Clin Infect Dis. 2022. PMID: 35404384. doi:10.1093/cid/ciac273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。